Justin A . Tolman, PharmD, PhD

Department

Pharmacy Sciences

Position

Associate Professor

Books

• Elsevier
  Tolman, J.A., Huslig, M. Aerosol Dosage Forms: Pulmonary Drug Delivery. In Pharmaceutics: Basic Principles and Application to Pharmacy Practice, Dash, A.K., Singh, S., Tolman, J.A. (Eds)
  1st Edition, p. 225-239 2013

Articles

• AAPS PharmSciTech
  D Vora, AE Kincaid, JA Tolman, H Cauhan, Vora D, Kincaid AE, Tolman J, Chauhan H. Characterization and Systemic Delivery of Dibenzoylmethane via the Intranasal Route. AAPS PharmSciTech. 2021;22(1):30. 2021
• Journal of Pharmaceutical Sciences
  Indapurkar, Amruta, Henriksen, Brian, Tolman, Justin, Fletcher, James Evaluation of triazole-chelated lanthanides as chemically stabile bioimaging agents
  102, p. 2589-2598 2013
• Elsevier
  Singh, S., Tolman, J.A. Biopolymers. In Pharmaceutics: Basic Principles and Application to Pharmacy Practice, Dash, A.K., Singh, S., Tolman, J.A.
  1st Edition, p. 139-150 2013
• Elsevier
  Tolman, J.A., Lambros, M. P., Membrane Transport and Permeation. In Pharmaceutics: Basic Principles and Application to Pharmacy Practice, Dash, A.K., Singh, S., Tolman, J.A. (Eds.).
  1st Edition, p. 307-315 2013
• Elsevier
  Hedaya, M. A., Tolman, J.A.. Routes of Drug Administration. In Pharmaceutics: basic Principles and Application to Pharmacy Practice. Dash, A.K., Singh, S., Tolman, J.A. (Eds.)
  1st Edition, p. 333-.348 2013
• Therapeutics and clinical risk management
  Tolman, J. A., Faulkner, M. A. Treatment options for refractory and difficult to treat seizures: focus on vigabatrin
  7, p. 367-375 2011
• Journal of Central Nervous System Disease
  Faulkner M., Tolman J.A. Safety and Efficacy of Vigabatrin for the Treatment of Infantile Spasms.
  3, p. 199-207 2011
• Drug Development and Industrial Pharmacy
  Tolman, Justin A., Williams, Robert O.,III Advances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on pharmacokinetic properties
  36, p. 1-30 2010
• Clinical Medicine Insights: Therapeutics
  Faulkner M., Tolman J.A. Vigabatrin in Refractory Complex Partial Seizures. The Evidence of its Therapeutic Value.
  2, p. 849-856 2010
• Expert Opinion on Pharmacotherapy
  Tolman, Justin A., Faulkner, Michele A. Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval
  10, p. 3077-3089 2009

Presentations

• Agrawal, P., Arte, K., North, E.J., Tolman, J.A. Expanding Global Tuberculosis Treatment Through a Novel Inhaled Clofazimine Product. Scientific Poster. AAPS 2020 PharmSci 360, American Association of Pharmaceutical Scientists. Virtual 2020
• Agrawal, P., Arte, K., North, E.J., Tolman, J.A.Improving Global Tuberculosis Treatment through a Novel Inhaled Drug-Device Combination Product. Scientific Poster. Global Health Conference Midwest. Omaha, NE 2020
• M. Huslig, A. Sabnis R. Fowler, N. Hanson, J. Tolman. An In Vitro Model of Bacterial Pneumonia. Abstract accepted for the 2014 American Association of Pharmaceutical Sciences Annual Meeting and Exposition, San Diego, CA 2014
• N. Navalkar, D. Patel, J. Tolman. Evaluation of Modified Liquid Impaction Surfaces in the Next generation Impactor (NGI). Abstract published in the Proceedings of the American Association of Pharmaceutical Scientists Annual Meeting. San Antonio, TX 2013
• M.Huslig, J. Tolman. Characterization of Spray Dried Nanoparticulate Chitosan Using a Novel Nebulizer Nozzle. Abstract published in the Proceedings of the American Association of Pharmaceutical Scientists Annual Meeting. Chicago, IL 2012

Foundation/Association

• Optimized Dry Powder Formulation and Delivery for Inhaled Clofazimine. Sponsoring Organization: SBIR Phase 1: Topic 051 Creare LLC, Hannover, NH. Funded (# HHSN 2722018000040C). Awarding organization: NIH/NIAID. With Dr. Jeffrey North

Awards

• Student selected teaching award from the Pharmacy Student Honors Society (Rho Chi)
  Rho Chi Excellence in Teaching Award

Consulting

• Consultant - Genelex Corporation
  Exernal Consultant
  Consultation on pharmacokinetic principles for improvement of the Algo-Improver Program.
  Genelex Corporation
  2014 - 2014